EXECUTIVE DIAGNOSTICS LLC NPI 1134699945

NPI Details

EXECUTIVE DIAGNOSTICS LLC is a clinical medical laboratory in Jackson, MS. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. EXECUTIVE DIAGNOSTICS LLC NPI is 1134699945. The provider is registered as an organization entity type.

The provider's business location address is:

5455 EXECUTIVE PL STE B
JACKSON, MS
ZIP 39206-104
Phone: (219) 395-0667

The provider's authorized official is Kirnjot Singh .
The authorized official title is President and has the following contact phone number (219) 395-0667.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Chemical analysis using chromatography technique (HCPCS:82542)
• Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Hemoglobin a1c level (HCPCS:83036)
• Bacterial colony count, urine (HCPCS:87086)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)

The enumeration date for this NPI number is 12/5/2018 and was last updated on 12/5/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: